Stem Cell Authority, Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCAL research report →
About the company
Stem Cell Authority, Ltd. (SCAL) is a technology innovation firm primarily focused on the retrieval and cryogenic storage of stem cells. The company excels at collecting and banking two specific types of stem cells: hematopoietic stem cells, sourced from umbilical cord blood, and "Miracle Mesenchymal" stem cells, derived from the Wharton's jelly found within a newborn's umbilical cord.
- CEO
- Carlzo Bernard Cardwell
- IPO
- 2005
- HQ
- Fairlawn, OH, US
Price Chart
- Market Cap
- $17.42K
- P/E
- -45.87
- P/S
- 0.00
- P/B
- -2.41
- EV/EBITDA
- -4.12
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 7.07%
- ROIC
- 5.25%
- Revenue
- $0 · 0.00%
- Net Income
- $-4,233 · 0.00%
- EPS
- $0.00 · 0.00%
- Op Income
- $-4,230
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.50
- Avg Volume
- 15.42K
Get TickerSpark's AI analysis on SCAL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SCAL coverage
Recent articles, reports, and earnings notes.
No research on SCAL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCAL report →Similar companies
Peers in the same neighborhood.